Brickell Biotech Inc (NASDAQ:BBI)
| 0.8965 Delayed Data As of 3:33pm ET |  -0.073 / -7.53%Today’s Change | 0.47 Today|||52-Week Range 2.61 | +14.86% Year-to-Date |
Latest BBI News | Press Releases
| Will Brickell (BBI) Report Negative Earnings Next Week? What You Should Know 3:00pm / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 0.97 |
| Today’s open | 0.98 |
| Day’s range | 0.89 - 0.98 |
| Volume | 8,923 |
| Average volume (3 months) | 3,200,830 |
| Market cap | $70.3M |
Data as of 3:33pm ET, 05/06/2021
Growth & Valuation
| Earnings growth (last year) | +81.04% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -76.99% |
| P/E ratio | NM |
| Price/Sales | 10.50 |
| Price/Book | 2.07 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CYCCCyclacel Pharmaceuti... | -0.26 | -3.81% |
| SYNSynthetic Biologics ... | -0.04 | -8.86% |
| DAREDare Bioscience Inc | -0.04 | -2.94% |
| ---- |
Data as of 3:59pm ET, 05/06/2021
Financials
| Next reporting date | May 14, 2021 |
| EPS forecast (this quarter) | -$0.12 |
| Annual revenue (last year) | $1.8M |
| Annual profit (last year) | -$20.9M |
| Net profit margin | -1,147.80% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Boulder, Colorado |
Forecasts
